Walgreens Boots Alliance (WBA) Expected to Announce Earnings on Thursday

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) is projected to release its earnings data before the market opens on Thursday, March 27th. Analysts expect Walgreens Boots Alliance to post earnings of $0.53 per share and revenue of $37.90 billion for the quarter. Walgreens Boots Alliance has set its FY 2025 guidance at 1.400-1.800 EPS and its FY25 guidance at $1.40-$1.80 EPS.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm had revenue of $39.50 billion for the quarter, compared to analysts' expectations of $37.40 billion. During the same quarter last year, the firm earned $0.66 EPS. The company's quarterly revenue was up 7.6% compared to the same quarter last year. On average, analysts expect Walgreens Boots Alliance to post $2 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock traded down $0.02 during trading hours on Friday, hitting $11.10. 37,249,707 shares of the company were exchanged, compared to its average volume of 20,812,172. The firm has a fifty day simple moving average of $10.96 and a 200 day simple moving average of $9.83. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance has a 52-week low of $8.08 and a 52-week high of $22.05. The stock has a market capitalization of $9.59 billion, a price-to-earnings ratio of -1.08, a P/E/G ratio of 1.31 and a beta of 0.62.

Remove Ads

Analysts Set New Price Targets

WBA has been the subject of several research analyst reports. Wolfe Research upgraded shares of Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Bank of America raised their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a research note on Monday, January 13th. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their price target for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. StockNews.com started coverage on shares of Walgreens Boots Alliance in a research note on Tuesday, March 18th. They set a "hold" rating for the company. Finally, Royal Bank of Canada lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research note on Wednesday, January 15th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.